Nymox Pharmaceutical
NYMX
#10265
Rank
โ‚ฌ15.82 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.12 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ5.66 Million, an increase over its 2021 earnings that were of -โ‚ฌ10.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.12 Million-62.64%
2022 -โ‚ฌ5.66 Million-47.71%
2021 -โ‚ฌ10.83 Million6.61%
2020 -โ‚ฌ10.15 Million-10.91%
2019 -โ‚ฌ11.4 Million24.24%
2018 -โ‚ฌ9.17 Million-20.03%
2017 -โ‚ฌ11.47 Million2.71%
2016 -โ‚ฌ11.17 Million-63.86%
2015 -โ‚ฌ30.9 Million674.44%
2014 -โ‚ฌ3.99 Million-6.11%
2013 -โ‚ฌ4.25 Million-35.66%
2012 -โ‚ฌ6.61 Million-20.76%
2011 -โ‚ฌ8.34 Million38.33%
2010 -โ‚ฌ6.03 Million35.59%
2009 -โ‚ฌ4.45 Million11.8%
2008 -โ‚ฌ3.98 Million-12.94%
2007 -โ‚ฌ4.57 Million8.85%
2006 -โ‚ฌ4.2 Million36.5%
2005 -โ‚ฌ3.08 Million-4.4%
2004 -โ‚ฌ3.22 Million-14.58%
2003 -โ‚ฌ3.77 Million
2001 -โ‚ฌ2.77 Million-20.54%
2000 -โ‚ฌ3.48 Million21.72%
1999 -โ‚ฌ2.86 Million-25.56%
1998 -โ‚ฌ3.84 Million101.3%
1997 -โ‚ฌ1.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.08 B-1,552,714.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.83 B-471,733.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.33 B-391,863.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ22.30 B-1,190,803.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.14 B-61,090.28%๐Ÿ‡บ๐Ÿ‡ธ USA